As you continue to work with the Distributed Bio™ experts, scientists, and contacts you know and trust, you’ll also have access to Charles River’s team of industry-leading scientists who excel at guiding large molecule development from lead discovery to IND.
This Distributed Bio™ antibody discovery and optimization platform create a unique end-to-end platform for therapeutic antibody programs. With the Distributed Bio acquisition, Charles River now offers an integrated target to clinic portfolio including:
Navigating the Early Stages of Drug Development
California Life Sciences professionals discuss navigating the early stages of drug development in this roundtable with experts from Charles River SSF, Westlake Village BioPartners, Rubido Life Sciences, and Nitrome Biosciences. Watch the video
Accelerate Your Cell Therapy R&D
Avoid common failures in late-preclinical and clinical stages of CAR oncology programs by conducting the right early discovery studies. Access the video series